PubMed Health⌕ Search

Biomedical subjects

J D Salisbury

Publications and source records attributed to J D Salisbury.

7 recordsLinked to original sources

Herpesvirus infection of cornea allografts.

This report describes three patients who have in common an occurrence of ocular epithelial herpes infection following a penetrating keratoplasty for a corneal opacity unrelated to herpesvirus infection. It may be that patients undergoing episodes of graft rejection are at increased risk for the reactivation of herpesvirus latent in the trigeminal ganglia, and corticosteroids should be used with this in mind. Because virtually all adults have been exposed to herpes and therefore harbor latent virus, a viral etiology should be considered for lesions in post-penetrating keratoplasty patients. Although the occurrence of this possibly rejection-related reactivation of herpes simplex virus is undoubtedly rare, management of potential cases of this nature should take this possibility into account.

Adult↗

Regenerative effects of epidermal growth factor after penetrating keratoplasty in primates.

Epidermal growth factor (EGF) was injected into the anterior chambers of 12 rhesus monkeys after the denudation of the central corneal endothelium during autograft transplantation. The animals were treated both at the time of surgery and three weeks after surgery. Clinical appearance and corneal thickness were monitored until the corneas were removed by penetrating keratoplasty ten weeks after the initial treatment. Flat preparations of the corneas showed significantly more endothelial cells in the central corneas of the EGF-treated eyes compared with the control eyes. These findings indicate that EGF is effective in replenishing the corneal endothelium after injury.

Animals↗

Suppression of corneal allograft rejection by cyclosporin A.

Corneal allografts can elicit a host immune response that results in their destruction as functional tissues. Just as with other types of tissue allografts, effective, safe methods are needed to prevent corneal allograft rejection in patients undergoing penetrating keratoplasty. In this study, cyclosporin A, a compound of fungal origin, was tested for its capacity to suppress corneal allograft rejection in rabbits. Corneal allografts were exchanged between pairs of randomly bred albino rabbits. Some animals received retrobulbar injections and others received similar injections of the drug vehicle only. Cyclosporin A significantly prolonged corneal allograft survival. All the allografts in untreated eyes were rejected within 40 days; four (45%) of the nine allografts in treated eyes survived more than 70 days. Cyclosporin A alone was less effective in suppressing allograft rejection in heavily vascularized, inflamed graft sites. No adverse side effects were seen when it was injected locally into the rabbit eye. We conclude that in the acute graft model in this study, cyclosporin A is a safe, potent immunosuppressive agent.

Animals↗

Blood group antigens on human corneal cells demonstrated by immunoperoxidase staining.

The ultrasensitive immunoperoxidase staining technique demonstrated the presence of blood groups A, B, and D antigens on human corneal epithelial and endothelial cells. Nonspecific staining was not seen and there was little antigen in the corneal stroma. Blood group antigens probably do not initiate corneal allograft rejection, but they may lend antigenic support to the rejection response one it has begun.

Antigens, Surface↗

Keratoconus.

1. Keratoconus is a bilateral corneal dystrophy that causes a central corneal thinning. The onset is after puberty. 2. Non-surgical treatment of keratoconus is accomplished best with the use of rigid gas permeable contact lenses. 3. Penetrating keratoplasty is the procedure of choice when contact lenses fail.

Adolescent↗